Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [35.174.62 ]

🍽️ mometasone furoate,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Anti-inflammatory Effects: Mometasone furoate exerts potent anti-inflammatory effects by inhibiting the production of inflammatory mediators and reducing immune responses associated with skin inflammation and allergic reactions. It helps alleviate symptoms such as redness, itching, swelling, and discomfort associated with inflammatory skin conditions.

  2. Skin Disorders: Mometasone furoate is commonly used to treat a wide range of skin disorders, including atopic dermatitis (eczema), contact dermatitis, seborrheic dermatitis, psoriasis, and allergic reactions. It helps relieve symptoms and improve the appearance of the skin affected by these conditions.

  3. Topical Application: Mometasone furoate is typically applied topically to the affected area of the skin in the form of creams, ointments, or lotions. It is absorbed into the skin and exerts its therapeutic effects locally, minimizing systemic side effects associated with oral corticosteroids.

  4. Nasal Allergies: Mometasone furoate is also available as a nasal spray and is used in the treatment of allergic rhinitis (hay fever) and nasal polyps. It helps reduce nasal congestion, sneezing, itching, and runny nose associated with allergic reactions.

  5. Safety and Side Effects: When used as directed, mometasone furoate is generally safe and well-tolerated. However, long-term or excessive use of topical corticosteroids may lead to side effects such as skin thinning, skin discoloration, acne, stretch marks, and increased susceptibility to skin infections. Nasal formulations may cause mild side effects such as nasal irritation, dryness, or nosebleeds.

  6. Pregnancy and Breastfeeding: The safety of mometasone furoate during pregnancy and breastfeeding has not been fully established. Pregnant or breastfeeding women should consult with their healthcare providers before using mometasone furoate to weigh the potential risks and benefits.

  7. Systemic Absorption: Although mometasone furoate is primarily used topically, some absorption into the bloodstream may occur, particularly with prolonged or extensive use, or when applied to thin or sensitive areas of the skin. Systemic absorption may increase the risk of systemic side effects associated with corticosteroid use.

  8. Precautions: Mometasone furoate should be used with caution in patients with certain medical conditions such as diabetes, immunosuppression, or compromised skin barrier function. It should not be applied to infected or open wounds unless directed by a healthcare provider.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations   |   βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of mometasone furoate,(prescription) On Probiotics

Rank Probiotic Impact

Bacteria Impacted by mometasone furoate,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Veillonella genus Decreases 👪 Source Study
Collinsella genus Decreases 👪 Source Study proinflammatory
Ruminococcus genus Decreases 👪 Source Study
Parabacteroides genus Decreases 👪 Source Study BMI, fat percent,blood pressure
Streptococcus genus Decreases 👪 Source Study
Coprococcus genus Decreases 👪 Source Study
Clostridium genus Decreases 👪 Source Study Pathogen
unclassified Robinsoniella no rank Decreases ⚗️ Source Study
unclassified Fusobacterium no rank Decreases ⚗️ Source Study
Eggerthellales order Decreases ⚗️ Source Study
Veillonella parvula species Decreases 📓 Source Study
Collinsella aerofaciens species Decreases 📓 Source Study
Ruminococcus bromii species Decreases 📓 Source Study
Parabacteroides distasonis species Decreases 📓 Source Study
Parabacteroides merdae species Decreases 📓 Source Study Infectious bacteria
Streptococcus salivarius species Decreases 📓 Source Study Infectious bacteria
Anaerofustis stercorihominis species Decreases ⚗️ Source Study
Asaccharospora irregularis species Decreases ⚗️ Source Study
Paraprevotella clara species Decreases ⚗️ Source Study
Slackia sp. NATTS species Decreases ⚗️ Source Study
Pseudoflavonifractor capillosus species Decreases ⚗️ Source Study
[Collinsella] massiliensis species Decreases ⚗️ Source Study
Parvibacter caecicola species Decreases ⚗️ Source Study
Coprococcus comes species Decreases 📓 Source Study
Clostridium perfringens species Decreases 📓 Source Study Food poisoning, gas gangrene
Coriobacterineae suborder Decreases ⚗️ Source Study
Chlamydiae/Verrucomicrobia group superphylum Decreases ⚗️ Source Study

Impact of mometasone furoate,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
ADHD 0.5 0 0
Age-Related Macular Degeneration and Glaucoma 0.2 -0.2
Allergic Rhinitis (Hay Fever) 0.3 0.3
Allergies 0.9 0.6 0.5
Allergy to milk products 0.3 0.2 0.5
Alopecia (Hair Loss) 1.1 1.1
Alzheimer's disease 0.3 0.9 -2
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0 0.3 0
Ankylosing spondylitis 1.7 0.3 4.67
Anorexia Nervosa 0.2 0.3 -0.5
Antiphospholipid syndrome (APS) 0.1 0.1
Asthma 0 0
Atherosclerosis 0.8 0 0
Atrial fibrillation 1.2 0.2 5
Autism 1.7 1.2 0.42
Barrett esophagus cancer 0.5 0.1 4
Bipolar Disorder 0.5 0.9 -0.8
Brain Trauma 0.4 0.4
Carcinoma 1.1 1 0.1
Celiac Disease 0.6 1 -0.67
Cerebral Palsy 0.7 0.3 1.33
Chronic Fatigue Syndrome 1.1 1.7 -0.55
Chronic Kidney Disease 0.2 0.5 -1.5
Chronic Obstructive Pulmonary Disease (COPD) 0.9 0 0
Chronic Urticaria (Hives) 0.7 0.7
Coagulation / Micro clot triggering bacteria 0.4 0.4 0
Colorectal Cancer 0.8 0.4 1
Coronary artery disease 0.8 0.5 0.6
COVID-19 2.4 1.8 0.33
Crohn's Disease 1.6 1 0.6
deep vein thrombosis 0.4 -0.4
Depression 1.4 3 -1.14
Dermatomyositis 0.1 0.1
Eczema 0.5 0.4 0.25
Endometriosis 0.4 0.8 -1
Eosinophilic Esophagitis 0.5 -0.5
Epilepsy 0.6 0.5 0.2
Fibromyalgia 0.6 0.1 5
Functional constipation / chronic idiopathic constipation 0.6 0.1 5
gallstone disease (gsd) 1.1 1.1
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.5 0.1 4
Generalized anxiety disorder 0.1 -0.1
giant cell arteritis 0 0
Glioblastoma 0.1 -0.1
Gout 0 0
Graves' disease 0.7 0.4 0.75
Halitosis 0.5 0.1 4
Hidradenitis Suppurativa 0.1 0.5 -4
hypercholesterolemia (High Cholesterol) 0 0
hyperglycemia 0.2 -0.2
Hyperlipidemia (High Blood Fats) 0.4 0.4 0
hypertension (High Blood Pressure 1.1 0.2 4.5
Hypothyroidism 0 0
Hypoxia 0.2 0.2
IgA nephropathy (IgAN) 0 0
Inflammatory Bowel Disease 0.8 2.5 -2.13
Insomnia 0.1 0.1
Intelligence 0.1 0.1
Intracranial aneurysms 0.5 0.4 0.25
Irritable Bowel Syndrome 0.8 0.7 0.14
Liver Cirrhosis 1.2 1 0.2
Long COVID 1.4 2.5 -0.79
Low bone mineral density 0 0
Lung Cancer 0.3 -0.3
ME/CFS with IBS 0.2 0.1 1
ME/CFS without IBS 0.3 0.6 -1
Metabolic Syndrome 2.1 0.7 2
Mood Disorders 3.2 3 0.07
multiple chemical sensitivity [MCS] 0.9 0.9
Multiple Sclerosis 0.9 1.4 -0.56
Multiple system atrophy (MSA) 0.3 -0.3
Neuropathy (all types) 0.1 0.1
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.6 0.4 0.5
Obesity 2.1 1.3 0.62
obsessive-compulsive disorder 1.5 0 0
Osteoarthritis 0.2 0.3 -0.5
Osteoporosis 0.8 0.8
pancreatic cancer 0.1 0.1
Parkinson's Disease 0.9 1 -0.11
Polycystic ovary syndrome 0.6 0.6 0
Postural orthostatic tachycardia syndrome 0 0 0
Premenstrual dysphoric disorder 0.4 0.2 1
primary biliary cholangitis 0.4 -0.4
Psoriasis 1.9 0.9 1.11
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 2.1 1 1.1
Rosacea 0.3 0 0
Schizophrenia 2.1 0.4 4.25
scoliosis 0 0.3 0
Sjögren syndrome 1.9 0.2 8.5
Sleep Apnea 0.4 0 0
Small Intestinal Bacterial Overgrowth (SIBO) 0.1 0.1
Stress / posttraumatic stress disorder 0.3 0.5 -0.67
Systemic Lupus Erythematosus 0.9 0.3 2
Tic Disorder 0.3 0.4 -0.33
Type 1 Diabetes 0.9 0.2 3.5
Type 2 Diabetes 2.1 0.7 2
Ulcerative colitis 0.2 0.3 -0.5
Unhealthy Ageing 0.7 0 0

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant. [35.174.62 ]